Dr. Victor Ayala, Ph.D is a Staff Scientist at Advanced Bioscience Laboratories, Inc (ABL) with the Cell Biology program in Rockville, MD. Dr. Ayala has more than 13 years of experience in immunology, animal models of infectious disease and genetic engineering. He did his postdoctoral training at the Frederick National Laboratory for Cancer Research where he gained experience in adoptive transfer studies in non-human primates. His postdoctoral research is focused on examining the role of virus-specific T cells controlling SIV infection. His group developed techniques to generate virus-specific cells using retroviral vector technology to introduce epitope-specific T cell receptors (TCR), chimeric antigen receptors (CAR) and homing markers. During his postdoctoral training, he acquired extensive experience in generating retroviral vectors, virus quantitation and assessing cellular and humoral immune responses. Dr. Ayala is currently involved in vaccine studies with the Simian Vaccine Evaluation Units (SVEU) and the Vaccine Research Program of the Division of AIDS, NIAID. He is also exploring the vector mediated antibody gene transfer.
HIV/SIV; Vaccines; Recombinant vectors; Genetic modification of primary cells (TCR, CAR, homing markers); Antibody engineering.